Local Time : 11:21 CET

MC 628 - Hybrid imaging in the female

Thursday, March 2, 10:30 - 12:00 Room: M 5 Session Type: Joint Course of ESR and RSNA (Radiological Society of North America): Hybrid Imaging Topics: Nuclear Medicine, Oncologic Imaging, Hybrid imaging Moderators: A. Drzezga (Cologne/DE), K. Riklund (Umea/SE) Add session to my schedule In your schedule (remove)

A-257 10:30

A. Pelvic tumours

F. Dehdashti; St. Louis/US

Learning Objectives

1. To learn about different tracers.
2. To understand how to interpret hybrid imaging examinations of the pelvis.
3. To learn about the role of hybrid imaging in staging, treatment evaluation and follow-up.

Abstract

This presentation summarizes the literature in PET/CT and PET/MRI in the evaluation of the three most common gynaecologic malignancies: cervical, endometrial and ovarian cancers. The advantages and challenges of each hybrid modality will be briefly discussed. In addition to clinically used 2-[18F]fluoro-2-deoxy-D-glucose (FDG), novel tracers such as 18F-fluorooestradiol (FES), an oestrogen-receptor imaging tracer, 3´-deoxy-3´-[18F]fluorothymidine (FLT), a proliferative tracer and 18F-fluoroazomycinarabinoside (FAZA), a hypoxic tracer that are currently used for research purposes in these malignancies will be briefly discussed.

A-258

B. Breast cancer

O. Ratib; Geneva/CH

Learning Objectives

1. To learn about pathophysiology and relation to different tracers.
2. To understand how to interpret hybrid imaging examinations of the breast.
3. To learn about the role of hybrid imaging in staging, treatment evaluation and follow-up.

Abstract

Hybrid imaging has gained important role in staging and treatment monitoring as well as in detection of recurrence of breast cancers. From SPECT-CT applications of bone metastases, to whole-body staging with PET-CT to the newer applications of hybrid PET-MR that allow to benefit from that added value of functional imaging and tissue characterization of MRI combined with metabolic and imaging biomarkers of PET. In this refresher course, we will review the current state of recommended applications of hybrid imaging in breast cancers. The basic applications of FDG - PET in staging of regional lymph nodes and distance metastases as well as its added value in monitoring the responses to neoadjuvent chemotherapy. Beyond these well-established applications a review of upcoming new tracers and their potential advantages will also be addressed. Finally a detailed evaluation of hybrid PET-MRI applications in management of breast cancers will be presented highlighting the added value of complementary information gathered from these two modalities.

A-259

C. Interactive case discussion (part 1)

F. Dehdashti; St. Louis/US

Learning Objectives

1. To understand how to interpret hybrid imaging in female pelvic tumours.
2. To understand how to interpret hybrid imaging in breast cancer.
3. To learn how to avoid common pitfalls.

Abstract

Imaging is critical for staging, determining prognosis and treatment strategy, and in predicting prognosis in gynaecological malignancies. In this case presentation session, common clinical applications of PET/CT and PET/MRI in the evaluation of the most common gynaecologic malignancies will be presented. In addition, the advantages and disadvantages of each hybrid modality will be illustrated and discussed.

A-260

C. Interactive case discussion (part 2)

O. Ratib; Geneva/CH

Learning Objectives

1. To understand how to interpret hybrid imaging in female pelvic tumours.
2. To understand how to interpret hybrid imaging in breast cancer.
3. To learn how to avoid common pitfalls.

Abstract

-

This website uses cookies. Learn more